Daily Archives: October 23, 2012

Warning and NOV Letter Summary – 3rd Quarter 2012

Each quarter Eye on FDA examines what has occurred in enforcement by the Office of Prescription Drug Promotion (OPDP), formerly known as the Division of Drug Marketing, Advertising, and Communications (DDMAC).  Apart from being instructive for those working in communications … Continue reading

Posted in Warning Letters | Comments Off on Warning and NOV Letter Summary – 3rd Quarter 2012